Document 0311
 DOCN  M9490311
 TI    Application of cost-effectiveness methodology to the consideration of
       needlestick-prevention technology.
 DT    9411
 AU    Laufer FN; Chiarello LA; Bureau of Health Economics, New York State
       Department of Health,; Albany 12237.
 SO    Am J Infect Control. 1994 Apr;22(2):75-82. Unique Identifier : AIDSLINE
       MED/94338020
 AB    Data from the study of needlestick-prevention devices in 10 New York
       State hospitals enabled application of cost-effectiveness analysis
       techniques for determining relative benefits of various safety
       interventions. This article introduces to infection control
       practitioners several economic concepts related to cost-effectiveness
       methodology and provides two examples of how they may be applied for
       decision-making purposes. A critical aspect of the analysis described is
       the determination of a base cost of needlestick injury. By applying
       decision analysis to experience-based data aggregated from participating
       institutions, base expected cost of needlestick injury was determined to
       be $363.
 DE    Comparative Study  Cost-Benefit Analysis/METHODS  Disease Transmission,
       Patient-to-Professional/PREVENTION &  CONTROL  Evaluation Studies
       Hepatitis B/TRANSMISSION  Hospital Costs  Hospitals, State/ECONOMICS
       Human  HIV Infections/TRANSMISSION  Infection Control/METHODS
       Infusions, Intravenous/ECONOMICS/*INSTRUMENTATION  Injections,
       Intravenous/ECONOMICS/*INSTRUMENTATION  Needlestick
       Injuries/*ECONOMICS/PREVENTION & CONTROL  New York  *Personnel, Hospital
       Risk Management/ECONOMICS  Workers' Compensation  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).